Kewaunee Scientific Corporation reported significant financial growth in its latest quarterly results, with net sales reaching $70.1 million for the three months ended October 31, 2025, compared to $47.8 million in the same period last year, marking a 46.7% increase. For the six-month period, sales totaled $141.2 million, up from $96.2 million, reflecting a 46.9% rise. The increase in revenue was primarily driven by the acquisition of Nu Aire, which contributed $19.4 million in revenue during the quarter. Despite the growth in sales, net earnings for the quarter decreased to $2.4 million, or $0.82 per diluted share, down from $3.0 million, or $1.01 per diluted share, in the prior year.
The company's gross profit margin for the quarter was 28.1%, slightly lower than the 29.2% margin reported in the same quarter last year. The decline in margin was attributed to the integration of Nu Aire and lower manufacturing volumes in the laboratory construction segment. Operating expenses increased to $15.6 million, or 22.3% of sales, compared to $9.5 million, or 19.9% of sales, in the prior year, largely due to higher costs associated with the Nu Aire acquisition and increased wages and benefits.
Kewaunee's order backlog stood at $192.9 million as of October 31, 2025, an increase from $184.4 million a year earlier, although it decreased from $214.6 million at the end of April 2025. The company reported a notable increase in domestic sales, which reached $55.2 million, up 51.7% from the previous year, while international sales rose by 31.0% to $14.9 million. The growth in international sales was attributed to the continued delivery of large projects booked in prior periods.
In terms of strategic developments, Kewaunee completed the acquisition of Nu Aire on November 1, 2024, for $55 million, which has expanded its product offerings in laboratory equipment. The acquisition is expected to enhance Kewaunee's market position and operational capabilities. The company has also entered into a new revolving credit facility with PNC Bank to support its liquidity needs, particularly in light of the recent acquisition. Looking ahead, Kewaunee remains focused on growth through both organic and inorganic means, with a strong backlog and ongoing investments in technology and processes to support its strategic objectives.
About KEWAUNEE SCIENTIFIC CORP /DE/
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. Its offerings include steel and wood casework, fume hoods, safety cabinets, incubators, and freezers. Serving global markets in pharmaceuticals, biotech, education, and healthcare, the company leverages a diversified product portfolio, international subsidiaries, and strategic acquisitions to meet the needs of laboratory and research facilities worldwide.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.